Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in its large healthcare insurance business and competition for its vast network of retail pharmacies.
CVS ousts CEO amid tanking shares, activist pressure: ‘Brewing for some time’
